ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Enlight Biosciences Creates Entrega

by Ann M. Thayer
January 17, 2011 | APPEARED IN VOLUME 89, ISSUE 3

Enlight Biosciences, a Boston-based firm established by PureTech Ventures and backed by several major pharmaceutical companies, has created an independent company called Entrega. The new firm will develop oral drug delivery technologies for administering proteins, peptides, and difficult-to-deliver small molecules. For its initial development work, Entrega will create orally bioavailable formulations of several biologic drugs from Enlight’s company partners. In return, Entrega will receive undisclosed up-front and research milestone payments.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment